Applied DNA Sciences (APDN) Tops Q2 EPS by 5c

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $1 million versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'